In the context of neuroblastoma, Theruvath et al. demonstrated that the combination of IgG anti-GD2 and anti-CD47 therapy enhanced macrophage-mediated phagocytosis of neuroblastoma cells in vitro synergistically and led to tumor eradication in mouse xenograft and syngeneic models [21]. The gene discussed is CD47; the disease is neoplasm.